Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

Study:

A Double-Blind Study Of Nutritional Intervention For The Treatment Of Cancer Cachexia Using JuvenĀ® Nutritional Supplement

Rationale:

Nutritional supplements may help prevent loss of appetite, weight loss, and fatigue in patients with advanced cancer.

Purpose:

Randomized phase III trial to compare the effectiveness of two nutritional supplements in preventing loss of appetite, weight loss, and fatigue in patients who have stage III or stage IV solid tumors.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Cachexia
Lymphoma
Lymphoproliferative Disorder
Unspecified Adult Solid Tumor, Protocol Specific
Dietary Supplement: Juven
Dietary Supplement: Non-Juven Supplement
Phase 3

Verified by Radiation Therapy Oncology Group October, 2013

Sponsored by: Radiation Therapy Oncology Group
Information provided by: Radiation Therapy Oncology Group
ClinicalTrials.gov identifier: NCT00053053

Study Type: Interventional

Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care

Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio 44195
United States

Lawrence B. Berk, MD, PhD., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site